HEALTHCARE & PHARMACEUTICALS MARKET RESEARCH
Category: Elderly Health
Everyone needs to be cared and looked after in our society and so do our elders
-
FDA approved Leqembi to have $12.9 billion sales
Leqembi (lecanemab), a recently approved medicine from Biogen/Eisai for the treatment of Alzheimer’s disease, was given FDA approval in January 2023
-
Assistive Technology Market; a $82B Growth Story
Assistive technology for the elderly refers to devices, tools, and systems designed to support older adults in their daily activities, enhance their independence, and improve their overall quality of life. With the use of assistive technology, people with disabilities can engage in civic activities, the job market, and lead a productive, independent existence. The use…
-
Respiratory Syncytial Virus; market value at US$9.53 billion
Respiratory Syncytial Virus (RSV) is a common and highly contagious virus that infects the respiratory tract, primarily affecting the lungs and airways.
Follow Us
Recent Posts
-
Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
-
FDA approved Leqembi to have $12.9 billion sales
-
Assistive Technology Market; a $82B Growth Story
Tags
Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila